AI-generated summary
The authors studied photobiomodulation therapy applied to fat-derived stem cells taken from diabetic rats, grown in the laboratory. They report higher cell viability and antioxidant gene expression, along with lower apoptosis, oxidative stress and cell doubling time, compared with untreated diabetic cells. These findings come from in vitro cell experiments in rats, not human patients.
- Who or what was studied
- Adipose-derived mesenchymal stem cells extracted from streptozotocin-induced diabetic rats (in vitro cell cultures)
- Wavelengths
- 630, 810 nm
- Limits stated in the abstract
- The study used cultured cells from rats rather than human participants, and the abstract reports no sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630 nm, 810 nm
- Energy density (fluence)
- 1.2 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Oxidative stress, Photobiomodulation, Reactive oxygen species, Photodynamic therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.